Intolerant Antibodies

South San Francisco, United States

Intolerant Antibodies is a biopharmaceuticals and healthcare company.

$1.1M raised

Jun 2024

Seed

Biopharma Biotechnology Health Care Life Science

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Intolerant Antibodies

How much funding has Intolerant Antibodies raised?

Intolerant Antibodies has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in June 2024.

Where is Intolerant Antibodies headquartered?

Intolerant Antibodies is headquartered in South San Francisco, United States.

What does Intolerant Antibodies do?

Intolerant Antibodies is a biopharmaceuticals and healthcare company.

What stage is Intolerant Antibodies at?

Intolerant Antibodies is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 12, 2024.

MLA

"Intolerant Antibodies — Funding & Investors." VCBacked, June 12, 2024, https://www.vcbacked.co/company/intolerant-antibodies. Accessed July 2, 2026.

APA

VCBacked. (2024). Intolerant Antibodies — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/intolerant-antibodies

Wikipedia (cite web)

{{cite web |title=Intolerant Antibodies — Funding & Investors |url=https://www.vcbacked.co/company/intolerant-antibodies |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 12, 2024.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.